Sponsors (33)
The bill gives prosecutors stronger extraterritorial tools to disrupt drug supply chains and creates clearer sentencing tiers, but it expands criminal exposure beyond U.S. borders and raises compliance costs and potential incarceration expenses for taxpayers and businesses.
U.S. law enforcement can target suppliers of foreign manufacturing equipment and chemicals used to produce illegal drugs, reducing the availability of illicit drugs in the United States and improving public health/safety.
Prosecutors gain clearer tools to pursue cross-border supply chains, improving the government's ability to disrupt large-scale drug trafficking networks and strengthen national security.
Creates penalty tiers tied to drug quantities/types, producing more predictable maximum sentences and sentencing outcomes for defendants and prosecutors.
The bill's extraterritorial reach and reliance on a 'reasonable cause to believe' standard may expose U.S. persons to prosecution for conduct that largely occurs outside the United States, raising civil liberties and due-process concerns.
Legitimate manufacturers, exporters, and government contractors could face criminal liability or much higher compliance and recordkeeping costs if customers misuse goods abroad, creating legal uncertainty and economic burdens for small businesses.
Expanded penalties may lead to longer prison terms for offenders, increasing incarceration costs for taxpayers and adding pressure to the prison system.
Based on analysis of 2 sections of legislative text.
Makes it a federal crime to manufacture or distribute equipment or chemicals abroad when the supplier knows or intends they will be used to make drugs unlawfully imported into the U.S., and sets new prison-term tiers.
Creates new federal criminal liability for people and companies overseas who make, sell, or supply machines, chemicals, or materials intended to produce controlled substances that will be illegally imported into the United States and increases maximum prison terms based on the type and quantity of items involved. Directs the U.S. Sentencing Commission to review and amend federal sentencing guidelines to align with the new statutory penalties.
Official title: To amend the Controlled Substances Act to prevent the importation of illicit pill press machines with the intent to counterfeit substances, and for other purposes.
Introduced January 21, 2026 by Addison P. McDowell · Last progress January 21, 2026